passage bio inc stock

Dive deeper with interactive charts and top stories of PASSAGE BIO INC. Company Type For Profit.

Passage Bio Stock Worth Keeping An Eye On Nasdaq Pasg Seeking Alpha

PASG stock price quote stock graph news analysis.

. Price and volume The chart has 1 X axis displaying. Company profile page for Passage Bio Inc including stock price company news press releases executives board members and contact information. Chart represents Passage Bio Inc.

Combination chart with 2 data series. Passage Bio Inc 202 019 1038 Watch. News Passage Bio IncPASG.

Primary metrics and data points about Passage Bio Inc. Find the latest Passage Bio Inc. Real time Passage Bio Inc.

Finally Citigroup dropped their price target on shares of Passage Bio from 1500 to 1000 and set a buy rating on the stock in a research note on Tuesday May 17th. Complete Passage Bio Inc. Passage Bio Inc is a genetic medicines company.

PASGs dividend yield history payout ratio proprietary DARS rating much more. The Price to Earnings PE ratio a key valuation measure is calculated by. Get the latest Passage Bio Inc.

Is followed by the analysts listed above. 1 day agoAccording to data from MarketBeat Passage Bio presently has an average rating of Buy and a consensus price target of 1450. 1 2021 at 831 am.

Price and volume over 1Y period View as data table Passage Bio Inc. Ad Direxion Daily PharmaMedical 3X Bull ETFs. ET by Tomi Kilgore Passage Bio downgraded to neutral from overweight at JP.

What was the 52-week high for Passage Bio stock. 25 2021 at 722 am. Get Passage Bio Inc PASGNASDAQ real-time stock quotes news price and financial information from CNBC.

The company is focused on developing transformative therapies for rare monogenic CNS disorders. It is focused on developing transformative therapies for central nervous system CNS disorders. PASG stock quote history news and other vital information to help you with your stock trading and investing.

Is a clinical-stage genetic medicines company. The company has a market cap of 10101 million a PE ratio of -053 and a beta of 185. 21 hours agoThe firm has a 50-day moving average of 249 and a 200-day moving average of 446.

Stock analysis for Passage Bio Inc PASGNASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. The company is based in Philadelphia PA and has a research collaboration and license agreement with the University of Pennsylvania Penn and its Gene Therapy Program GTP. Price and volume The chart has 1 X axis displaying.

It has pipeline products such as GM1 Gangliosidosis. Dont Settle For Less. Passage Bio started at outperform with 26 stock price target at Wedbush Jan.

Ad Dont miss out on opportunities open an account in 10 minutes. Passage Bio Inc NASDAQPASG Passage Bio Inc. Passage Bio Inc NASDAQPASG Passage Bio Inc.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Company facts information and financial ratios from MarketWatch. Real-time trade and investing ideas on Passage Bio Inc PASG from the largest community of traders and investors.

The 1 Source For Dividend Investing. PASG stock news and headlines to help you in your trading and investing decisions. Passage Bio is a fully integrated gene therapy company with a mission to develop a portfolio of five life-transforming AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases.

No significant news for PASG in the past two years. Please note that any opinions estimates or forecasts regarding Passage Bio Incs performance made by these analysts are theirs alone and do not represent opinions forecasts or predictions of Passage Bio. Passage Bio has a.

Passage Bio is a genetic medicines company focused on developing transformative therapies for central nervous system disorders with limited or no approved treatment options. Passage Bio has a one year low of 157 and a one year high of 1614. The company is based in Philadelphia PA and.

Stock quote and chart Stock Information. The average twelve-month price target for Passage Bio is 1700 with a. Passage Bio NASDAQPASG - Get Rating last announced its quarterly earnings data on Monday May 16th.

FMR LLC is the second largest shareholder owning 98. Rooms Shows Rankings Earnings Newsletters Shop. If you are looking for stocks with good return Passage Bio Inc stock can be a bad high-risk 1-year investment option.

Its first product candidate PBGM01 utilizes AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal beta-galactosidase β-gal for gangliosidosis GM1. These are breaking news delivered the minute it happens. Get the latest Passage Bio Inc PASG real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions.

According to the current price Passage Bio is 1089 away from the 52-week high. Common Stock PASG Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Passage Bio stock opened at 176 on Friday.

The high in the last 52 weeks of Passage Bio stock was 1625.

Kynr59iytvoxhm